CD8A and nonpapillary renal cell carcinoma: ccRCC-01_PDO and ccRCC-06_PDO showed abundant T lymphocytes infiltration in TME, which could be classified as CD8+ inflamed subtype and predicted to be responsive to immunotherapy.